Pediatric onset Behçet disease

Current Opinion in Rheumatology

Volumn 22, Issue 5, 2010, Pages 585-589

  Özen, Seza ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Beh et disease; child; epidemiology; treatment

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ANTIBODY;

APHTHOUS STOMATITIS; BEHCET DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHILDHOOD DISEASE; CLINICAL FEATURE; ERYTHEMA NODOSUM; EYE INFLAMMATION; FOLLICULITIS; GASTROINTESTINAL DISEASE; GENETIC ASSOCIATION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE; BEHCET SYNDROME; CHILD; GENETICS; ONSET AGE; PREVALENCE;

AGE OF ONSET; BEHCET SYNDROME; CHILD; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PREVALENCE;

EID: 77955176101     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32833cc9b7     Document Type: Review

References (25)

1. Mahr A, Belarbi L, Wechsler B, et al. Population-based prevalence study of Behcet's disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008; 58:3951-3959.
2. Calamia KT, Wilson FC, Icen M, et al. Epidemiology and clinical characteristics of Behcet's disease in the US: a population-based study. Arthritis Rheum 2009; 61:600-604.
3. Dursun A, Durakbasi-Dursun HG, Dursun R, et al. Angiotensin-converting enzyme gene and endothelial nitric oxide synthase gene polymorphisms in Behcet's disease with or without ocular involvement. Inflamm Res 2009. [Epub ahead of print]
4. Ben Dhifallah I, Houman H, Khanfir M, Hamzaoui K. Endothelial nitric oxide synthase gene polymorphism is associated with Behcet's disease in Tunisian population. Hum Immunol 2008; 69:661-665.
5. Park KS, Baek JA, Do JE, et al. CTLA4 gene polymorphisms and soluble CTLA4 protein in Behcet's disease. Tissue Antigens 2009; 74:222-227.
6. Du L, Yang P, Hou S, et al. No association of CTLA-4 polymorphisms with susceptibility to Behcet disease. Br J Ophthalmol 2009; 93:1378-1381.
7. Boiardi L, Atzeni F, Casali B, et al. Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behcet's disease. Clin Exp Rheumatol 2009; 27 (2 Suppl 53):S43-S47.
8. Ben Dhifallah I, Lachheb J, Houman H, Hamzaoui K. Toll-like-receptor gene polymorphisms in a Tunisian population with Behcet's disease. Clin Exp Rheumatol 2009; 27 (2 Suppl 53):S58-S62.
9. Kim J, Im CH, Kang EH, et al. Mannose-binding lectin gene-2 polymorphisms and serum mannose-binding lectin levels in Behcet's disease. Clin Exp Rheumatol 2009; 27 (2 Suppl 53):S13-S17.
10. Touitou I, Magne X, Molinari N, et al. MEFV mutations in Behcet's disease. Hum Mutat 2000; 16:271-272.
11. Kappen JH, Wallace GR, Stolk L, et al. Low prevalence of NOD2 SNPs in Behcet's disease suggests protective association in Caucasians. Rheumatology (Oxford, England) 2009; 48:1375-1377.
12. Fei Y, Webb R, CobbBL, etal. Identification of novel genetic susceptibility loci for Behcet's disease using a genome-wide association study. Arthritis Res Ther 2009; 11:R66
13. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990; 335:1078-1080.
14. Kesen MR, Goldstein DA, Tessler HH. Uveitis associated pediatric Behcet disease in the American midwest. Am J Ophthalmol 2008; 146:819-827.
15. Citirik M, Berker N, Songur MS, et al. Ocular findings in childhood-onset Behcet disease. J AAPOS 2009; 13:391-395.
16. SungurGK, Hazirolan D, Yalvac I, et al. Clinical and demographic evaluation of Behcet disease among different pediatric age groups. Br J Ophthalmol 2009; 93:83-87.
17. Kitaichi N, Miyazaki A, Stanford MR, et al. Low prevalence of juvenile-onset Behcet's disease with uveitis in east/south Asian people. Br J Ophthalmol 2009; 93:1428-1430.
18. Ozen S. The 'other' vasculitis syndromes and kidney involvement. Pediatr Nephrol 2009. [Epub ahead of print]
19. Ozen S, Bilginer Y, Besbas N, et al. Behçet disease: treatment of vascular involvement in children. Eur J Pediatr 2010; 169:427-430.
20. Yesilot N, Bahar S, Yilmazer S, et al. Cerebral venous thrombosis in Behçet's disease compared to those associated with other etiologies. J Neurol 2009; 256:1134-1142.
21. Siva A, Saip S. The spectrum of nervous system involvement in Behç et's syndrome and its differential diagnosis. J Neurol 2009; 256: 513-529.
22. Arida A, Vaiopoulos G, Markomichelakis N, et al. Are clusters of patients with distinct clinical expression present in Behç et's disease? Clin Exp Rheumatol 2009; 27 (2 Suppl 53):S48-S51.
23. Hatemi G, Silman A, Bang D, et al., EULAR Expert Committee. EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008; 67:1656-1662.
24. Davatchi F, Sadeghi Abdollahi B, Tehrani Banihashemi A, et al. Colchicine versus placebo in Behç et's disease: randomized, double-blind, controlled crossover trial. Mod Rheumatol 2009; 19:542-549.
25. Cantarini L, Tinazzi I, Caramaschi P, et al. Safety and efficacy of etanercept in children with juvenile-onset Behcets disease. Int J Immunopathol Pharmacol 2009; 22:551-555.